Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsCurrent Deferred RevenueCurrent LeasesCurrent TaxesFinished GoodsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxNon-Current AssetsNon-Current DebtNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Collegium Pharmaceutical (COLL) Receivables - Other (2024)

Historic Receivables - Other for Collegium Pharmaceutical (COLL) over the last 1 years, with Q4 2024 value amounting to $25.0 million.

  • Collegium Pharmaceutical's Receivables - Other changed N/A to $25.0 million in Q4 2024 from the same period last year, while for Dec 2024 it was $25.0 million, marking a year-over-year change of. This contributed to the annual value of $25.0 million for FY2024, which is N/A changed from last year.
  • Latest data reveals that Collegium Pharmaceutical reported Receivables - Other of $25.0 million as of Q4 2024.
  • Collegium Pharmaceutical's 5-year Receivables - Other high stood at $25.0 million for Q4 2024, and its period low was $25.0 million during Q4 2024.